Physician

Pathology

Wang practices Pathology. She researched medicine at Hunan Medical University. Wang is a published MD. She has 44 papers published. The most current publication "Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy." Wang accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell Acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations.
• Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
• The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic Leukemia.
• Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with Acute lymphoblastic leukaemia.
• Mutational profiling of therapy-related myelodysplastic syndromes and Acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
• The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acut...
• Chronic Myelomonocytic Leukemia with Nucleophosmin (NPM1) Mutation.
• Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation.
• Identification of a novel fusion gene, IRF2BP2-RARA, in Acute promyelocytic leukemia.
• High p53 protein expression in therapy-related Myeloid neoplasms is associated with adverse karyotype and poor outcome.
• Flow Cytometry Immunophenotypic Findings in Chronic Myelomonocytic Leukemia and Its Utility in Monitoring Treatment Response.
• MLL gene amplification in Acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation.
• Hematopathology: SC14-1 CHALLENGES IN BONE MARROW PATHOLOGY.
• Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
• De novo Acute myeloid leukemia with 20-29% blasts is less aggressive than Acute myeloid leukemia with ≥30% blasts in older adults: A Bone Marrow Pathology Group study.
• Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms.
• Cytogenetic risk stratification of 417 patients with chronic myelomonocytic Leukemia from a single institution.
• Leukemic Phase of ALK(+) Anaplastic Large-Cell Lymphoma, Small-Cell Variant: Clinicopathologic Pitfalls of a Rare Entity.
• Atypical chronic myeloid Leukemia (aCML) BCR-ABL1-negative is clinicopathologically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms (MDS/MPN-...
• The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
• Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic Acute myeloid leukemia.
• Bone marrow fibrosis in patients with primary Myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
• Clinicopathologic Features of CD5-Positive Nodal Marginal Zone Lymphoma.
• Sequential lymphomas or clonally unrelated richter syndrome of chronic lymphocytic Leukemia into mantle cell lymphoma.
• Toll-like receptor alterations in Myelodysplastic syndrome.
• Clonally related composite follicular Lymphoma and mantle cell Lymphoma with clinicopathologic features and biological implications.
• MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell Lymphoma patients treated with rituximab-CHOP immunochemotherapy.
• The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related Myelodysplastic syndromes.
• Systemic mastocytosis with associated clonal hematological non-mast cell lineage Disease: Clinical significance and comparison of chomosomal abnormalities in SM and AH...
• Potential therapeutic biomarkers in plasma Cell myeloma: A flow cytometry study.
• CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes.
• Usefulness of CD11a and CD18 in Flow Cytometric Immunophenotypic Analysis for Diagnosis of Acute Promyelocytic Leukemia.
• FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic Leukemia.
• Multi-color CD34(+) progenitor-focused flow cytometric assay in evaluation of Myelodysplastic syndromes in patients with post cancer therapy cytopenia.
• Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
• Immunophenotypic heterogeneity of normal plasma Cells: comparison with minimal residual plasma Cell myeloma.
• High-grade B cell Lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements an...
• Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow Diseases, with emphasis on diagnostic pitfal...
• Cytogenetic abnormalities in a series of 1,029 patients with primary Myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal ...
• Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic Cell neoplasm: case report and literature review.
• Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with Myeloid neoplasms.
• Dyspoietic changes associated with hepatosplenic T-cell Lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
• Risk stratification of chromosomal abnormalities in chronic myelogenous Leukemia in the era of tyrosine kinase inhibitor therapy.

Schools

---

• Hunan Chinese Med College

Conditions Treated

---

• Acute Leukemia
• Anemia
• Chronic Myeloid Leukemia (CML)
• Hodgkin's Disease
• View All

Doctors Specialties

---

• Hematology
• Hematopathology
• Pathology

Accepted Insurances

---

Education

---

• Massachusetts General Hospital
• Yale-New Haven Hospital
• Hunan Medical University

Hospital

---

• University of Texas M.D. Anderson Cancer Center

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1093798845
Last Name Of The Provider	WANG
First Name Of The Provider	SA
View All

Similar Doctors

---

	Dr. Putao Cen, MD This Doctor is OpenDoctor Recommended.
	Dr. Russell R. Broaddus, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jordan U. Gutterman, MD This Doctor is OpenDoctor Recommended.
	Dr. Jing Liu, MD This Doctor is OpenDoctor Recommended.
	Dr. Ralf Hatch, MD This Doctor is OpenDoctor Recommended.
	Dr. Rebecca F. Yorke, MD This Doctor is OpenDoctor Recommended.
	Dr. Adriana Olar, MD This Doctor is OpenDoctor Recommended.
	Dr. Aditya Shetty, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog